World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
141
Citations
77260
World Ranking
1618
National Ranking
942

Overview

Keith D. Lindor is affiliated with Arizona State University in the United States and has an extensive body of research primarily in the field of Medicine, with specific focus on Hepatology, Surgery, Pulmonary and Respiratory Medicine, Epidemiology, and Oncology.

Their research work covers multiple specialized topics, including:

  • Liver Diseases and Immunity
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gallbladder and Bile Duct Disorders
  • Liver Disease Diagnosis and Treatment
  • Drug Transport and Resistance Mechanisms
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Diversity and Career in Medicine

Keith D. Lindor has authored notable recent papers such as:

  • "Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases" (2021), published in Hepatology
  • "Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase" (2020), published in The American Journal of Gastroenterology

Other frequently cited recent contributions in the field, though authored by collaborators, appear in major journals including The American Journal of Gastroenterology, Gastroenterology, Hepatology International, and Liver International.

The scientist has collaborated frequently with:

  • Gideon M. Hirschfield
  • Annarosa Floreani
  • Albert Parés
  • Christophe Corpechot
  • Marco Carbone

Publication venues where the researcher's work appears most often include:

  • Hepatology
  • Liver International
  • The American Journal of Gastroenterology
  • Journal of Gastroenterology
  • Gastroenterology

Their contributions engage deeply with liver-related diseases, immunology, and treatment strategies, reflecting a wide scope within both clinical and epidemiological aspects of hepatic medicine.

Best Publications

  • The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

    Leon A. Adams;James F. Lymp;Jenny St. Sauver;Schuyler O. Sanderson

  • The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

    Paul Angulo;Jason M. Hui;Giulio Marchesini;Ellisabetta Bugianesi

  • Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

    Paul Angulo;Jill C. Keach;Kenneth P. Batts;Keith D. Lindor

  • Primary Biliary Cirrhosis

    Keith D. Lindor;M. Eric Gershwin;Raoul Poupon;Marshall Kaplan

  • Nonalcoholic fatty liver disease

    Leon A. Adams;Paul Angulo;Keith D. Lindor

  • The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.

    Leon A. Adams;Schuyler Sanderson;Keith D. Lindor;Paul Angulo

  • Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.

    Ariel E Feldstein;Ali Canbay;Paul Angulo;Makiko Taniai

  • Non-alcoholic fatty liver disease.

    Paul Angulo;Keith D Lindor

  • A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

    F. Nevens;P. Andreone;G. Mazzella;S. I. Strasser

  • Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy

    Amaar Ghazale;Suresh T. Chari;Lizhi Zhang;Thomas C. Smyrk

  • Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.

    Keith D. Lindor;Kris V. Kowdley;E. Jenny Heathcote;M. Edwyn Harrison

  • Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.

    Jacqueline Laurin;Keith D. Lindor;Jeffrey S. Crippin;Andrea Gossard

  • High Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis

    Keith D. Lindor;Kris V. Kowdley;Velimir A.C. Luketic;M. Edwyn Harrison

  • Ursodiol for Primary Sclerosing Cholangitis

    Keith D. Lindor

  • Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

    RE Poupon;KD Lindor;K Cauch-Dudek;ER Dickson

  • Risk Factors and Comorbidities in Primary Biliary Cirrhosis: A Controlled Interview-Based Study of 1032 Patients

    M. Eric Gershwin;Carlo Selmi;Carlo Selmi;Howard J. Worman;Ellen B. Gold

  • Association of Non-Alcoholic Fatty Liver Disease With Chronic Kidney Disease: A Systematic Review and Meta-Analysis

    Giovanni Musso;Roberto Gambino;James H. Tabibian;Mattias Ekstedt

  • Primary Biliary Cholangitis: 2018 Practice Guidance From the American Association for the Study of Liver Diseases

    Keith D. Lindor;Christopher L. Bowlus;James Boyer;Cynthia Levy

  • Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

    Darell S. Pardi;Edward V. Loftus;Walter K. Kremers;Jill C. Keach

  • Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid

    Gideon M. Hirschfield;Andrew Mason;Velimir Luketic;Velimir Luketic;Keith Lindor;Keith Lindor

Frequent Co-Authors

Paul Angulo
Paul Angulo University of Kentucky
Kris V. Kowdley
Kris V. Kowdley Washington State University
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Albert Parés
Albert Parés University of Barcelona
Bettina E. Hansen
Bettina E. Hansen University Health Network
Cyriel Y. Ponsioen
Cyriel Y. Ponsioen University of Amsterdam
Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternatives to traditional medical school? The healthcare field offers a wide range of online degrees catering to different interests and career goals. One rapidly growing area is medical coding certification online, which prepares students for in-demand medical billing and coding jobs—vital roles for the administrative backbone of healthcare.

For those aiming for clinical roles, there are flexible options such as cheapest np school programs. These online nurse practitioner courses offer affordable ways to advance your nursing career, sometimes allowing you to specialize while balancing life or work commitments.

Many aspiring nurses also consider nursing school online, which delivers a blend of coursework and hands-on training. These programs can lead to RN, BSN, or advanced nursing roles.

For those aiming for academia or leadership, pursuing phd nursing programs online can open doors to research and policy-making positions. No matter your pathway, online degrees in healthcare are more accessible and affordable than ever before.

Best Scientists Citing Keith D. Lindor

Trending Scientists

Recently Published Articles